Bioworld Financial Watch articles from April 2003

Bioworld Financial Watch archives from April 2003

Regeneron's Axokine story continues; subset holds hope.
April 7, 2003... "It's all Axokine," said analyst Steven Harr with Morgan Stanley in New York, earlier this month. He was trying to explain the market's so-what reaction to Regeneron Pharmaceuticals Inc.'s handsome deal with Novartis AG, of Basel,...

Money Raised by Biotech in 2003 Vs. 2002.
April 7, 2003... Money Raised By Biotech In 2003 Vs. 2002 Millions Jan. 1 - April 3, 2003: Jan. 1 - April 4, 2002: $1,699.75M $5,039.58M Public/Other * 394 ...

10 Biggest U.S. Gainers & Losers for the Week.
April 7, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Insmed 75.75 Biogen 5.73 Spectrum 65.83 Digene 4.48 CytRx 63.64 Sepracor 2.46...

Public Financing of Biotechnology: March 2003.
April 7, 2003... Public Financing Of Biotechnology: March 2003 1. COMMENCED TRADING IN MARCH INITIAL OFFERINGS Company Date Date Shares/ Price Shares Lead, Other Gross (Symbol) Filed Comm. Units (M) Out Underwriters...

Other Financings of Public Biotechnology Companies: March 2003.
April 7, 2003... Other Financings Of Public Biotechnology Companies: March 2003 TOTAL: $76.5M Company Type Of Number Of Amount (Symbol) # Financing Shares, Units Raised Or...

Venture Capital and Corporate Investments in Biotechnology Companies: March 2003.
April 7, 2003... Venture Capital And Corporate Investments In Biotechnology Companies: March 2003 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $371.25M Company Location Date Amt. (M) Acadia San Diego...

Money Raised by Biotech in 2003: January-March.
April 7, 2003... Money Raised By Biotech In 2003: January-March Type of J ($M) F ($M) M ($M) Total ($M) financing Public offerings 254.2 81.9 169.9 506.0 Private biotechs 277.7 144.6 371.3 793.6 Public/other ...

Biotech Stock in 2003.
April 7, 2003... These graphs compare the performance of the biotech stocks in 2003 using two different measures. The BioWorld Stock Indicator measures the average percent change year-to-date in the 265 U.S. biotech and biotech-related stocks that are...

BioWorld Stock Report for Public Biotechnology Companies.
April 7, 2003... BioWorld Stock Report For Public Biotechnology Companies Close Close %Change Company Symbol 3/28 4/4 WK YTD Aastrom Biosci ASTM 0.3 0.369...

Midwest states come together for BIO event, plan advancement.
April 14, 2003... CHICAGO -- Eight state biotechnology associations came together to create a conference aimed at the industry as it exists in the Midwest. And it does exist there, thank you, albeit with less cash and with an approach to drug discovery (and...

10 Biggest U.S. Gainers & Losers for the Week.
April 14, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) MacroChem 128.26 SangStat Med 2.55 Curis 71.08 LION bioscience 1.00 GenVec 52.63 Cytogen 0.94...

Clinical trials update: March 2003.
April 14, 2003... Clinical Trials Update: March 2003 AUTOIMMUNE Company * Product Description (Country; Symbol) Amgen Inc. Enbrel Etanercept; tumor (AMGN) necrosis...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: March 2003.
April 14, 2003... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: March 2003 Company * Product Description (Country; Symbol) CANCER Axcan Pharma Photofrin Photosensitive...

FDA submissions, approvals and other actions: March 2003.
April 14, 2003... FDA Submissions, Approvals And Other Actions: March 2003 Company * Product Description (Country; Symbol) CANCER Lorus GTI-2040 Antisense anticancer Therapeutics ...

BioWorld stock report for public biotechnology companies.
April 14, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change Vol 4/4 4/11 WK YTD (000) Aastrom Biosci ASTM 0.369 0.36 ...

London Stock Exchange.
April 14, 2003... LONDON STOCK EXCHANGE Company Symbol 4/4 4/11 %WK %YTD Volume Acambis ACM 257 273.5 6.42 -1.26 1623 Antisoma ASM 20.75 22.25 7.23 -22.61 4225 British Biotech BBG...

Toronto Stock Exchange.
April 14, 2003... TORONTO STOCK EXCHANGE Company Symbol 4/4 4/11 %WK %YTD Volume Adherex AHX 0.33 0.35 6.06 -18.60 92 Angiotech Pharma ANP 31.91 31.5 -1.28 -41.20 103 Anormed ...

Pioneer Genentech deserves credit for pipeline, analyst says.
April 21, 2003... Investors are likely to be all ears this week when Genentech Inc. hosts its annual meeting with stockholders. A recent earnings report and other news from the pioneering company -- the industry's oldest, often cited by analysts as an example of...

10 Biggest U.S. Gainers & Losers for the Week.
April 21, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Sima Thera 56.30 Martek Bio 3.84 Diacrin 42.34 ICOS 2.89 Pain Therapeu 39.57 Amgen 2.25 CytRx ...

Grants and Awards to Biotech Companies: Jan. 1 - April 16, 2003.
April 21, 2003... Grants And Awards To Biotech Companies: Jan. 1 - April 16, 2003 Company * Funding Amount (Symbol) Institution (M) 3rd Millennium Inc. * Department of $0.75 ...

BioWorld Stock Report for Public Biotechnology Companies.
April 21, 2003... BioWorld Stock Report For Public Biotechnology Companies Close Close % Change Vol Company Symbol 4/11 4/18 * WK YTD (000) Astrom Blosci ASTM 0.36 0.36 ...

London Stock Exchange.
April 21, 2003... LONDON STOCK EXCHANGE Company Symbol 4/11 4/18 * %WK %YTD Volume Acambis ACM 273.5 268.5 -1.83 -3.07 2715 Antisoma ASM 22.25 22.5 1.12 -21.74 240 British Biotech ...

Toronto Stock Exchange.
April 21, 2003... TORONTO STOCK EXCHANGE Company Symbol 4/11 4/18 * %WK %YTD Volume Adherex AHX 0.35 0.35 0.00 -18.60 23 Angiotech Pharma ANP 31.5 30.97 -1.68 -42.19 198 Anormed ...

Psoriasis survey finds market robust, room for many winners.
April 28, 2003... Familiarity may breed contempt in some settings, but in the prescription world it often means a leg up on competing drugs. Such appears to be the case with Enbrel (etanercept), Amgen Inc.'s rheumatoid arthritis treatment approved in 1998. ...

Money Raised By Biotech.
April 28, 2003... Money Raised By Biotech In 2003 Vs. 2002 Jan. 1 - April 24, 2003: Jan. 1 - April 25, 2002: $1,939.15M $6,343.24M Public/Other * 453 ...

10 Biggest U.S. Gainers & Losers for the Week.
April 28, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) NeoRx Corp. 252.94 Genzyme 4.90 Vion Pharma 151.52 Integra LifeSci 3.80 EntreMed 144.66 ICOS 3.14...

Biotechnology Company Deals With Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, Feb. 20 - April 2003.
April 28, 2003... Biotechnology Company Deals With Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, Feb. 20 - April 2003 Company * Company * (Country; (Country; Symbol) Symbol) ...

Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, Feb. 20 - April 23, 2003.
April 28, 2003... Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, Feb. 20 - April 23, 2003 Company * Company * (Country; Symbol) Biogen Inc. InnaPhase Corp.* (BGEN) ...

Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Feb. 20 -- April 23, 2003.
April 28, 2003... Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Feb. 20 -- April 23, 2003 Company * Company * (Country; (Country; Symbol) Symbol) Acambis plc ...

Biotech -- Biotech Collaborations: Modified And Terminated Agreements, Feb. 20 -- April 23, 2003.
April 28, 2003... Biotech -- Biotech Collaborations: Modified And Terminated Agreements, Feb. 20 -- April 23, 2003 I. MODIFIED AGREEMENTS Company * Company * Change from original (Country; (Country; ...

Bio World Stock Report For Public Biotechnology Companies.
April 28, 2003... Bio World Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 4/18 4/25 WK YTD Aastrom Biosci ASTM 0.36 0.4 ...